EMD Serono Newsroom

To keep up with the latest news in real-time, subscribe to our email alerts, and follow us on Twitter, Facebook and LinkedIn. If you are a reporter and have questions about the company, please contact us

Latest News

 

Sep 20, 2019

Rockland, MA and New York, US, September 20, 2019 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced...

Sep 11, 2019

Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan MET exon 14 skipping alterations and MET amplifications are present in 3-5% of...

Sep 10, 2019

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the initiation of two global pivotal Phase III trials (EVOLUTION RMS 1 and 2)...

Aug 28, 2019

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that it will present data on its approved and investigational multiple...

  All Press Releases